Clinical Trial Update: Assessment of Systemically Administered Torisel Delivery to Brain Tumors by Intratumoral Microdialysis [Phase 1]

View source ↗

Summary

A Phase 1 trial assessing systemic temsirolimus delivery to brain tumors via intratumoral microdialysis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Neoplasms

Drugs mentioned

• Torisel (Temsirolimus)

Snippet

Sponsor: Emory University | Conditions: Brain Neoplasms | Phase 1 | Status: WITHDRAWN